aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Monmouth Junction, New Jersey, Gyros is a pioneering organization specializing in automated micro-immunoassays for therapeutic protein development. Their core mission is to enhance the efficiency of immunoassay processes, significantly reducing the time required for assay optimization from weeks to days. Gyros offers the Gyrolab platform, an automated and versatile analytical tool that supports various applications such as serology assays, PK assays, and biomarker analysis. Their market focus includes biopharmaceutical companies and research institutions aiming to streamline therapeutic protein development.
Gyros has garnered attention for its innovative technology and significant impact on the biopharmaceutical industry. Notable affiliated individuals and investors include key figures in biotech and pharmaceutical sectors who recognize the value of Gyros' contributions. The company's achievements include widespread adoption of the Gyrolab platform, which has set new standards for assay transfer ease and process development efficiency. Overall, Gyros has made a substantial impact by accelerating therapeutic protein development and clinical evaluations, thereby fostering advancements in medical research and treatment.
Operating Status
Active
Main Product(s)
Immunoassays, Protein Development
Technology
Automation
Tags
Biotech, SaaS
Model Types
Hardware, Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Small Business
Geographic Exposure
Americas
When was Gyros founded?
Gyros was founded in 2000.
Where is Gyros’s headquarters located?
Gyros’s headquarters is located in Ensenada, BCN, MX.
When was Gyros’s last funding round?
Gyros’s most recent funding round was for $10.4M (USD) in July 2009.
How many employees does Gyros have?
Gyros has 75 employees as of Feb 4, 2024.
How much has Gyros raised to-date?
As of July 05, 2023, Gyros has raised a total of $39.9M (USD) since Jul 6, 2009.
Add Comparison
Total Raised to Date
$39.9M
USD
Last Update Jul 6, 2009
Last Deal Details
$10.4M
USD
Jul 6, 2009
Series C
Total Employees Over Time
75
As of Feb 2024
Gyros Address
Ensenada,
Baja California
Mexico
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts